Brief: Cue Health Awarded New $28 Million Federal Contract To Develop Flu A/B, Rsv, Covid-19 Molecular Multiplex Test
03/08/2023 21:45
Aug 3 (Reuters) - Cue Health Inc HLTH.O :
* CUE HEALTH AWARDED NEW $28 MILLION FEDERAL CONTRACT TO
DEVELOP
FLU A/B, RSV, COVID-19 MOLECULAR MULTIPLEX TEST FOR BOTH
OVER-THE-COUNTER AND POINT-OF-CARE USE
Source text for Eikon: ID:nBw4T24vZa
Further company coverage: HLTH.O
Recent news on Cue Health
See all newsNASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
U.S. STOCKS ON THE MOVE-Salesforce, Birkenstock, Kohls Corp
U.S. STOCKS ON THE MOVE-Marathon Oil, Faraday Future, Semler Scientific
Brief: Cue Health Inc On May 16, Terminated Its Loan And Security Agreement, Dated June 30, 2022